SEC Form SC 13G filed by Teleflex Incorporated

8/10/22 2:59:39 PM ET

Medical/Dental Instruments

Health Care

Get the next $TFX alert in real time by email

SC 13G 1 tfx13gjul22.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) TELEFLEX INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 879369106 (CUSIP NUMBER) July 31, 2022 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. Rowe Price Investment Management, Inc. 85-4328500 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 2,647,818 6. Shared Voting Power* 0 7. Sole Dispositive Power* 7,572,040 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 7,572,040 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 16.1% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. 1. Name of Reporting Person T. ROWE PRICE MID-CAP GROWTH FUND, INC. 52-1784828 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 2,450,000 6. Shared Voting Power* 0 7. Sole Dispositive Power* 0 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 2,450,000 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 5.2% 12. Type of Reporting Person IV *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: TELEFLEX INC Item 1(b) Address of Issuer's Principal Executive Offices: 550 E SWEDESFORD RD, SUITE 400, WAYNE, PENNSYLVANIA 19087 Item 2(a) Name of Person(s) Filing: (1) T. Rowe Price Investment Management, Inc. (Price Investment Management) (2) T. ROWE PRICE MID-CAP GROWTH FUND, INC. X Attached as Exhibit A is a copy of an agreement between the Persons Filing (as specified hereinabove) that this Schedule 13G is being filed on behalf of each of them. Item 2(b) Address of Principal Business Office: 101 E. Pratt Street, Baltimore, MD 21201 Item 2(c) Citizenship or Place of Organization: (1) Maryland (2) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 879369106 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 X Investment Company registered under Section 8 of the Investment Company Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class Not Applicable Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Investment Management does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Investment Management serves as investment adviser. Any and all discretionary authority which has been delegated to Price Investment Management may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Investment Management which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Investment Management. (2) With respect to securities owned by any one of the T. Rowe Price Funds, only the custodian for each of such Funds, has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. No other person is known to have such right, except that the shareholders of each such Fund participate proportionately in any dividends and distributions so paid. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. Rowe Price Investment Management, Inc. Date: August 10, 2022 Signature: /s/ Mary Ann Picciotto Name & Title: Mary Ann Picciotto, Vice President T. ROWE PRICE MID-CAP GROWTH FUND, INC. Date: August 10, 2022 Signature: /s/ Mary Ann Picciotto Name & Title: Mary Ann Picciotto, Vice President 07/31/2022 EXHIBIT A AGREEMENT JOINT FILING OF SCHEDULE 13G Price Investment Management, Inc. (an investment adviser registered under the Investment Advisers Act of 1940), and T. ROWE PRICE MID-CAP GROWTH FUND, INC., all of which are Maryland corporations, hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934. It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other party unless such party knows or has reason to believe that such information is inaccurate. It is understood and agreed that a copy of this Agreement shall be attached as an exhibit to the statement on Schedule 13G, and any amendments hereto, filed on behalf of each of the parties hereto. T. Rowe Price Investment Management, Inc. Date: August 10, 2022 Signature: /s/ Mary Ann Picciotto Name & Title: Mary Ann Picciotto, Vice President T. ROWE PRICE MID-CAP GROWTH FUND, INC. Date: August 10, 2022 Signature: /s/ Mary Ann Picciotto Name & Title: Mary Ann Picciotto, Vice President

Get the next $TFX alert in real time by email

Recent Analyst Ratings for

$TFX

Date	Price Target	Rating	Analyst
7/1/2024	$205.00 → $245.00	Neutral → Overweight	Piper Sandler
12/4/2023	$261.00	Equal-Weight → Overweight	Morgan Stanley
6/21/2023		Buy → Hold	Needham
5/30/2023	$293.00	Buy	CL King
5/30/2023	$261.00	Equal-Weight	Morgan Stanley
4/26/2023		Outperform → Peer Perform	Wolfe Research
10/26/2022	$220.00	Neutral	Mizuho
10/14/2022	$305.00	Overweight	Stephens

More analyst ratings

SEC Form SC 13G filed by Teleflex Incorporated

Chat with this insight

Recent Analyst Ratings for $TFX

$TFX Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Teleflex Incorporated

Amendment: SEC Form SC 13G/A filed by Teleflex Incorporated

SEC Form SC 13G/A filed by Teleflex Incorporated (Amendment)

$TFX SEC Filings

SEC Form 10-Q filed by Teleflex Incorporated

Teleflex Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

Teleflex Incorporated filed SEC Form 8-K: Other Events

$TFX Press Releases

Fastest customizable press release news feed in the world

Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference

Teleflex to Present at the Jefferies London Healthcare Conference

Teleflex Announces Quarterly Dividend

$TFX Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$TFX Financials

Live finance-specific insights

$TFX Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$TFX Market Insights

Live Market Insights

$TFX Leadership Updates

Live Leadership Updates

Teleflex upgraded by Piper Sandler with a new price target

Teleflex upgraded by Morgan Stanley with a new price target

Teleflex downgraded by Needham

Teleflex Announces Quarterly Dividend

Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook

Teleflex Announces Third Quarter 2024 Earnings Conference Call Information

Corp. VP & CAO Deren John covered exercise/tax liability with 16 shares, decreasing direct ownership by 0.80% to 1,977 units (SEC Form 4)

Director Randle Stuart A exercised 2,674 shares at a strike of $121.00 and sold $638,899 worth of shares (2,674 units at $238.93) (SEC Form 4)

Amendment: Corp VP, Mfg and Supply Winters James was granted 1,126 shares, increasing direct ownership by 44% to 3,712 units (SEC Form 4)

Teleflex Announced The Establishment Of The Teleflex Center For Antimicrobial Protection As A Strategic Branch Of Its Vascular Access Business Unit Led By Chuck Gartner, Director Of Marketing - Strategic Initiatives

A Glimpse Into The Expert Outlook On Teleflex Through 4 Analysts

Truist Securities Maintains Hold on Teleflex, Raises Price Target to $240

3D Systems Announces Establishment of Medical Advisory Board & Appointment of Dr. Stephen K. Klasko as Chair

DW Healthcare Partners and Linden Announce Sale of Z-Medica to Teleflex

Recent Analyst Ratings for
$TFX

$TFX
Large Ownership Changes

$TFX
SEC Filings

$TFX
Press Releases

$TFX
Analyst Ratings

$TFX
Financials

$TFX
Insider Trading

$TFX
Market Insights

$TFX
Leadership Updates